From: Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
Treatment modality | % Expression of HIF-1α positive cells (p value) | % Expression of CAIX positive cells (p value) |
---|---|---|
AZ | 71 ± 0.70 (p < 0.001) | 82 ± 0.11 (p = 0.0138) |
MS-275 | 34 ± 0.23 (p < 0.001) | 27 ± 0.33 (p < 0.001) |
AZ + MS-275 | 17 ± 0.73 (p < 0.001) | 10 ± 0.16 (p < 0.001) |